Sign In

Sarcoma Clinical Trials

Protocol No.PITitle
OSU-11083Arvinder BhinderA Randomized Controlled Study of YONDELIS¿¥ (Trabectedin) or Dacarbazine for the Treatment of Advanced Liposarcoma or Leiomyosarcoma Previously Treated With an Anthracycline and Ifosfamide
OSU-12099Arvinder BhinderA Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin Alone in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
OSU-9952Albert de la ChapelleStorage of DNA/RNA for the Discovery of Genes Involved in Cancer Predisposition - A Tissue Collection Study
OSU-13014James HanjePre-chemotherapy hepatitis B screening and treatment reduces mortality related to hepatitis B reactivation In patients receiving chemotherapy
OSU-09102Craig HofmeisterA Phase I Study of AR-42 in Adult Patients with Advanced or Recurrent Hematologic Malignancies and Solid Tumors, for Which No Standard Therapy is Available
OSU-09077Joanne LesterDevelopment of An Educational Intervention to Enhance Interdisciplinary Spiritual Care for Cancer Patients
OSU-10025Stephen PovoskiRestrospective Evaluation of Patients Undergoing Surgery and Same-Day Intravenous Administration of 18F-FDG
OSU-12018Robert WesolowskiA Phase 1b Study to Assess the Safety of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors